Our Purpose
The Clinical Proteomics Platform aims to exploit the latest technological developments in mass spectrometry and immunoassay for the discovery, validation and use of biomarkers in various human pathologies (proteins, RNA, DNA, metabolites).
Our Approach
Several technological approaches oriented towards the use of clinical samples and high throughput are available, including mass spectrometry (MRM and HRMS) and ultra-sensitive immunoassays (SIMOA and MSD).
Our Mission
Integrated in the Montpellier Proteome Cluster since its creation and IBiSA labeled, its mission is equally to make medical, biological and technical expertise in Clinical Proteomics available to academic and industrial teams. The PPC has been ISO 9001 certified since 2014.
Latest news :
ASMS 2024 in Anaheim
The PPC squat attended the American Society For Mass Spectrometry (ASMS) conference last week, and each of them presented a poster. Thank you to everyone who came to see us with interest and curiousity, it was great being there! Laura Fichter: Proteome and Tau...
Research meeting
Montpellier University Hospital launches ‘Les rendez-vous de la recherche’. To mark International Clinical Research Day, stands were set up at Montpellier University Hospital, and the PPC was also present! The aim was to showcase clinical research projects for the...
The fight against cancer
Association Des étoiles dans la mer, vaincre le glioblastome, an association dedicated to the fight against glioblastoma, interviewed Professor Christophe Hirtz on the crucial role of RNA in the diagnosis of glioblastoma. For more information, go check the interview:...
The PPC in a nutshell :
Employees
Years of experience
Ongoing projects
Patents
Clinical Proteomics Platform
Institute for Regenerative Medicine & Biotherapy (IRMB)
Hôpital Saint Eloi
80 rue Augustin Fliche
34295 MONTPELLIER – Cedex 5
FRANCE